U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381738) titled 'Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders' on Jan. 20.
Brief Summary: This clinical trial is designed as a single-arm, two-center, open-label, prospective study. All participants are enrolled in the standard-dose unrelated umbilical cord blood transplantation group to evaluate the efficacy and safety of unrelated umbilical cord blood transplantation in treating Epstein-Barr virus-associated lymphoproliferative disease.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Epstein-Barr Virus-associated Lymphoproliferative Diseases
Chronic Active Epstein-Barr Virus Infection
EBV...